Portfolio Holdings Detail for ISIN IE00BZ173V67
Stock Name / Fund iShares MSCI USA SRI UCITS ETF EUR Hedged (Dist)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker 3SUR(EUR) ETF Plus

Holdings detail for INCY

Stock Name	Incyte Corporation
Ticker	INCY(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US45337C1027
LEI	549300Z4WN6JVZ3T4680

Show aggregate INCY holdings

News associated with INCY

Incyte Reaches Analyst Target Price: In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $84.18, changing hands for $84.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-09-18 08:17:02
Incyte Reports Encouraging 24-Week Results From Phase 3 STOP-HS Program Of Povorcitinib: (RTTNews) - Incyte Corporation (INCY) on Wednesday announced encouraging 24-week data from the pivotal Phase 3 STOP-HS program evaluating povorcitinib in adults with hidradenitis suppurativa (HS). - 2025-09-17 03:26:09
Incyte Corporation (NASDAQ:INCY) Short Interest Update: Incyte Corporation (NASDAQ:INCY – Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 15th, there was short interest totaling 9,600,000 shares, an increase of 29.4% from the July 31st total of 7,420,000 shares. Based on an average trading volume of 1,860,000 shares, the […] - 2025-09-11 04:51:36
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts: Incyte Corporation (NASDAQ:INCY – Get Free Report) has been assigned a consensus recommendation of “Hold” from the eighteen analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have issued a buy rating on the company. The […] - 2025-08-26 02:32:54
Incyte (NASDAQ:INCY) Given New $73.00 Price Target at JPMorgan Chase & Co.: Incyte (NASDAQ:INCY – Free Report) had its price objective increased by JPMorgan Chase & Co. from $67.00 to $73.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. A number of other research firms also recently commented on INCY. Citigroup upped their price objective on […] - 2025-08-25 03:08:46
LABU, INCY, UTHR, REGN: ETF Outflow Alert: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Charles Schwab Investment Management Inc. Purchases 38,962 Shares of Incyte Corporation (NASDAQ:INCY): Charles Schwab Investment Management Inc. raised its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 2.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,682,029 shares of the biopharmaceutical company’s stock after purchasing an additional 38,962 […] - 2025-08-13 05:43:01
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Citigroup Raises Incyte (NASDAQ:INCY) Price Target to $103.00: Incyte (NASDAQ:INCY – Get Free Report) had its price objective lifted by equities researchers at Citigroup from $88.00 to $103.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Citigroup’s target price suggests a potential upside of 37.54% from the […] - 2025-08-01 04:32:55
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts: Shares of Incyte Corporation (NASDAQ:INCY – Get Free Report) have earned a consensus rating of “Hold” from the eighteen research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, twelve have given a hold recommendation and five have assigned a buy recommendation to the […] - 2025-08-01 03:04:43
Incyte Reaches Analyst Target Price: In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $76.09, changing hands for $77.38/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-07-30 10:12:59
Mutual of America Capital Management LLC Sells 478 Shares of Incyte Corporation (NASDAQ:INCY): Mutual of America Capital Management LLC lessened its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,719 shares of the biopharmaceutical company’s stock after selling 478 shares during the quarter. […] - 2025-07-22 08:02:58
Incyte Corporation (NASDAQ:INCY) Shares Sold by Ballentine Partners LLC: Ballentine Partners LLC trimmed its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 12.2% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 4,686 shares of the biopharmaceutical company’s stock after selling 649 shares during the quarter. Ballentine Partners LLC’s holdings in Incyte were worth $284,000 at the end of the most recent […] - 2025-07-17 05:12:56
Cerity Partners LLC Has $8.04 Million Stock Position in Incyte Corporation (NASDAQ:INCY): Cerity Partners LLC lifted its holdings in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 103.5% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 132,703 shares of the biopharmaceutical company’s stock after buying an additional 67,495 shares during the period. Cerity Partners LLC owned […] - 2025-07-16 05:40:51
Incyte (NASDAQ:INCY) Price Target Cut to $67.00 by Analysts at JPMorgan Chase & Co.: Incyte (NASDAQ:INCY – Get Free Report) had its price objective decreased by equities research analysts at JPMorgan Chase & Co. from $68.00 to $67.00 in a report released on Monday,Benzinga reports. The firm currently has a “neutral” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of […] - 2025-07-16 04:26:52
Sheila A. Denton Sells 599 Shares of Incyte Corporation (NASDAQ:INCY) Stock: Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Sheila A. Denton sold 599 shares of the company’s stock in a transaction that occurred on Wednesday, July 2nd. The shares were sold at an average price of $68.61, for a total value of $41,097.39. Following the completion of the sale, the executive vice president owned 26,504 […] - 2025-07-09 06:12:52
Incyte Corporation (NASDAQ:INCY) EVP Barry P. Flannelly Sells 10,903 Shares of Stock: Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Barry P. Flannelly sold 10,903 shares of the stock in a transaction that occurred on Thursday, July 3rd. The shares were sold at an average price of $68.15, for a total transaction of $743,039.45. Following the sale, the executive vice president directly owned 39,744 shares of the […] - 2025-07-08 06:54:44
Incyte Corporation (NASDAQ:INCY) EVP Sells $587,248.55 in Stock: Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Vijay K. Iyengar sold 8,617 shares of the company’s stock in a transaction dated Thursday, July 3rd. The stock was sold at an average price of $68.15, for a total transaction of $587,248.55. Following the completion of the sale, the executive vice president directly owned 37,701 shares […] - 2025-07-08 06:20:54
Incyte Corporation (NASDAQ:INCY) Shares Sold by Vontobel Holding Ltd.: Vontobel Holding Ltd. trimmed its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 16.8% in the first quarter, Holdings Channel.com reports. The institutional investor owned 7,875 shares of the biopharmaceutical company’s stock after selling 1,592 shares during the quarter. Vontobel Holding Ltd.’s holdings in Incyte were worth $477,000 as of its most recent filing […] - 2025-07-08 04:46:50
Sumitomo Mitsui Trust Group Inc. Purchases 25,844 Shares of Incyte Corporation (NASDAQ:INCY): Sumitomo Mitsui Trust Group Inc. increased its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 5.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 473,186 shares of the biopharmaceutical company’s stock after purchasing an additional 25,844 shares […] - 2025-07-03 05:25:07
Incyte Corporation (NASDAQ:INCY) Shares Purchased by Chevy Chase Trust Holdings LLC: Chevy Chase Trust Holdings LLC raised its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 0.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 84,241 shares of the biopharmaceutical company’s stock after purchasing an additional 334 shares during the quarter. […] - 2025-06-27 05:36:52
Janney Montgomery Scott LLC Boosts Stock Position in Incyte Corporation (NASDAQ:INCY): Janney Montgomery Scott LLC grew its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 10.2% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 29,793 shares of the biopharmaceutical company’s stock after purchasing an additional 2,746 shares during the period. Janney Montgomery Scott LLC’s holdings in Incyte were worth $1,804,000 as of its […] - 2025-06-27 04:26:49
State of Alaska Department of Revenue Purchases 590 Shares of Incyte Corporation (NASDAQ:INCY): State of Alaska Department of Revenue lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 3.2% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,824 shares of the biopharmaceutical company’s stock after acquiring an additional 590 shares […] - 2025-06-26 05:56:50
Kentucky Retirement Systems Insurance Trust Fund Makes New Investment in Incyte Corporation (NASDAQ:INCY): Kentucky Retirement Systems Insurance Trust Fund bought a new stake in Incyte Corporation (NASDAQ:INCY – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,624 shares of the biopharmaceutical company’s stock, valued at approximately $280,000. A number […] - 2025-06-26 05:03:09
Incyte Corporation (NASDAQ:INCY) Shares Acquired by Wealth Enhancement Advisory Services LLC: Wealth Enhancement Advisory Services LLC lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 66.5% during the 1st quarter, HoldingsChannel.com reports. The fund owned 79,735 shares of the biopharmaceutical company’s stock after acquiring an additional 31,851 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Incyte were worth $4,828,000 […] - 2025-06-26 04:30:52
Assenagon Asset Management S.A. Has $536,000 Stock Position in Incyte Corporation (NASDAQ:INCY): Assenagon Asset Management S.A. raised its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,846 shares of the biopharmaceutical company’s stock after acquiring an additional 2,418 shares during the period. […] - 2025-06-20 04:54:50
Incyte Corporation (NASDAQ:INCY) Shares Sold by Exchange Traded Concepts LLC: Exchange Traded Concepts LLC lowered its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 41.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,117 shares of the biopharmaceutical company’s stock after selling 12,867 shares during the period. Exchange Traded Concepts […] - 2025-06-19 05:43:03
Fifth Third Bancorp Has $551,000 Holdings in Incyte Corporation (NASDAQ:INCY): Fifth Third Bancorp raised its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.0% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 9,103 shares of the biopharmaceutical company’s stock after acquiring an additional 179 shares during the quarter. Fifth Third Bancorp’s holdings in Incyte were worth $551,000 at the end of […] - 2025-06-18 04:56:49
Incyte (NASDAQ:INCY) Raised to “Buy” at Stifel Nicolaus: Incyte (NASDAQ:INCY – Get Free Report) was upgraded by equities researchers at Stifel Nicolaus from a “hold” rating to a “buy” rating in a research report issued on Monday, MarketBeat reports. The brokerage currently has a $107.00 price objective on the biopharmaceutical company’s stock, up from their previous price objective of $75.00. Stifel Nicolaus’ price […] - 2025-06-18 02:22:54
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War: The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 13:23:43

iShares MSCI USA SRI UCITS ETF EUR Hedged (Dist) INCY holdings

Date	Number of INCY Shares Held	Base Market Value of INCY Shares	Local Market Value of INCY Shares	Change in INCY Shares Held	Change in INCY Base Value	Current Price per INCY Share Held	Previous Price per INCY Share Held
2025-12-02 (Tuesday)	44,274	USD 4,491,155	USD 4,491,155	0	USD -26,564	USD 101.44	USD 102.04
2025-12-01 (Monday)	44,274	USD 4,517,719	USD 4,517,719	0	USD -107,143	USD 102.04	USD 104.46
2025-11-28 (Friday)	44,274	USD 4,624,862	USD 4,624,862	-141	USD -67,583	USD 104.46	USD 105.65
2025-11-27 (Thursday)	44,415	USD 4,692,445	USD 4,692,445	0	USD 0	USD 105.65	USD 105.65
2025-11-26 (Wednesday)	44,415	USD 4,692,445	USD 4,692,445	0	USD 4,442	USD 105.65	USD 105.55
2025-11-25 (Tuesday)	44,415	USD 4,688,003	USD 4,688,003	-385	USD -71,549	USD 105.55	USD 106.24
2025-11-24 (Monday)	44,800	USD 4,759,552	USD 4,759,552	-70	USD 180,120	USD 106.24	USD 102.06
2025-11-21 (Friday)	44,870	USD 4,579,432	USD 4,579,432	0	USD 13,461	USD 102.06	USD 101.76
2025-11-20 (Thursday)	44,870	USD 4,565,971	USD 4,565,971	-72	USD 12,448	USD 101.76	USD 101.32
2025-11-19 (Wednesday)	44,942	USD 4,553,523	USD 4,553,523	-105	USD -126,410	USD 101.32	USD 103.89
2025-11-18 (Tuesday)	45,047	USD 4,679,933	USD 4,679,933	-175	USD -30,843	USD 103.89	USD 104.17
2025-11-17 (Monday)	45,222	USD 4,710,776	USD 4,710,776	0	USD 905	USD 104.17	USD 104.15

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of INCY by Blackrock for IE00BZ173V67

Show aggregate share trades of INCY

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-28 SELL -141 106.990 103.850 104.164 USD -14,687 82.90 Loss of -2,999 on sale
2025-11-25 SELL -385 107.605 105.160 105.405 USD -40,581 82.18 Loss of -8,942 on sale
2025-11-24 SELL -70 106.670 102.503 102.920 USD -7,204 81.92 Loss of -1,470 on sale
2025-11-20 SELL -72 103.225 101.080 101.295 USD -7,293 81.49 Loss of -1,426 on sale
2025-11-19 SELL -105 104.660 100.300 100.736 USD -10,577 81.27 Loss of -2,044 on sale
2025-11-18 SELL -175 107.265 103.790 104.137 USD -18,224 81.02 Loss of -4,046 on sale
2025-11-14 SELL -210 106.920 103.770 104.085 USD -21,858 80.49 Loss of -4,954 on sale
2025-11-12 SELL -1,050 109.275 106.810 107.056 USD -112,409 79.88 Loss of -28,534 on sale
2025-11-10 SELL -71 108.810 104.070 104.544 USD -7,423 79.23 Loss of -1,797 on sale
2025-11-07 SELL -35 106.400 103.810 104.069 USD -3,642 78.91 Loss of -881 on sale
2025-11-05 SELL -70 106.470 101.500 101.997 USD -7,140 78.26 Loss of -1,662 on sale
2025-10-29 SELL -245 90.180 94.420 93.996 USD -23,029 77.08 Loss of -4,145 on sale
2025-10-23 SELL -70 89.310 89.560 89.535 USD -6,267 76.29 Loss of -927 on sale
2025-10-21 SELL -70 87.300 87.480 87.462 USD -6,122 75.96 Loss of -805 on sale
2025-10-16 SELL -35 87.310 92.860 92.305 USD -3,231 75.47 Loss of -589 on sale
2025-10-14 SELL -140 85.960 86.160 86.140 USD -12,060 75.11 Loss of -1,544 on sale
2025-09-26 SELL -70 82.700 82.950 82.925 USD -5,805 73.86 Loss of -635 on sale
2025-09-18 SELL -70 86.000 86.070 86.063 USD -6,024 73.50 Loss of -879 on sale
2025-08-21 SELL -140 86.530 86.970 86.926 USD -12,170 71.84 Loss of -2,111 on sale
2025-08-20 SELL -175 86.200 86.370 86.353 USD -15,112 71.55 Loss of -2,591 on sale
2025-08-18 SELL -105 84.920 87.240 87.008 USD -9,136 70.95 Loss of -1,686 on sale
2025-08-12 SELL -595 81.610 81.820 81.799 USD -48,670 70.37 Loss of -6,800 on sale
2025-08-07 SELL -420 78.200 78.250 78.245 USD -32,863 69.77 Loss of -3,560 on sale
2025-08-04 SELL -70 78.040 78.250 78.229 USD -5,476 69.35 Loss of -621 on sale
2025-07-31 SELL -70 74.890 77.460 77.203 USD -5,404 69.04 Loss of -572 on sale
2025-07-30 SELL -455 77.550 78.770 78.648 USD -35,785 68.80 Loss of -4,481 on sale
2025-07-29 SELL -245 77.380 77.870 77.821 USD -19,066 68.55 Loss of -2,270 on sale
2025-07-28 SELL -315 70.160 70.930 70.853 USD -22,319 68.51 Loss of -739 on sale
2025-07-22 SELL -35 68.900 69.120 69.098 USD -2,418 68.44 Loss of -23 on sale
2025-07-18 BUY 36 67.860 69.430 69.273 USD 2,494 68.50
2025-07-17 BUY 35 68.940 69.650 69.579 USD 2,435 68.48
2025-07-16 SELL -280 69.230 69.420 69.401 USD -19,432 68.45 Loss of -265 on sale
2025-07-15 SELL -210 68.250 70.150 69.960 USD -14,692 68.46 Loss of -315 on sale
2025-07-10 BUY 210 70.340 70.620 70.592 USD 14,824 68.39
2025-07-09 SELL -175 68.720 69.300 69.242 USD -12,117 68.38 Loss of -152 on sale
2025-07-08 SELL -960 67.670 68.650 68.552 USD -65,810 68.41 Loss of -141 on sale
2025-06-26 SELL -35 70.810 71.500 71.431 USD -2,500 68.36 Loss of -107 on sale
2025-06-24 SELL -119 69.010 69.540 69.487 USD -8,269 68.37 Loss of -133 on sale
2025-06-20 SELL -720 68.460 69.190 69.117 USD -49,764 68.44 Loss of -485 on sale
2025-06-17 SELL -1,500 68.810 70.890 70.682 USD -106,023 68.44 Loss of -3,362 on sale
2025-06-13 SELL -175 67.750 68.960 68.839 USD -12,047 68.21 Loss of -110 on sale
2025-06-12 BUY 170 69.220 69.540 69.508 USD 11,816 68.08
2025-06-09 SELL -385 69.890 69.960 69.953 USD -26,932 67.17 Loss of -1,071 on sale
2025-06-06 SELL -105 68.770 68.980 68.959 USD -7,241 66.77 Loss of -230 on sale
2025-06-04 SELL -665 67.420 68.450 68.347 USD -45,451 66.21 Loss of -1,421 on sale
2025-06-03 SELL -175 67.110 70.970 70.584 USD -12,352 65.31 Loss of -923 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-28	SELL	-141	106.990	103.850	104.164	USD -14,687	82.90 Loss of -2,999 on sale
2025-11-25	SELL	-385	107.605	105.160	105.405	USD -40,581	82.18 Loss of -8,942 on sale
2025-11-24	SELL	-70	106.670	102.503	102.920	USD -7,204	81.92 Loss of -1,470 on sale
2025-11-20	SELL	-72	103.225	101.080	101.295	USD -7,293	81.49 Loss of -1,426 on sale
2025-11-19	SELL	-105	104.660	100.300	100.736	USD -10,577	81.27 Loss of -2,044 on sale
2025-11-18	SELL	-175	107.265	103.790	104.137	USD -18,224	81.02 Loss of -4,046 on sale
2025-11-14	SELL	-210	106.920	103.770	104.085	USD -21,858	80.49 Loss of -4,954 on sale
2025-11-12	SELL	-1,050	109.275	106.810	107.056	USD -112,409	79.88 Loss of -28,534 on sale
2025-11-10	SELL	-71	108.810	104.070	104.544	USD -7,423	79.23 Loss of -1,797 on sale
2025-11-07	SELL	-35	106.400	103.810	104.069	USD -3,642	78.91 Loss of -881 on sale
2025-11-05	SELL	-70	106.470	101.500	101.997	USD -7,140	78.26 Loss of -1,662 on sale
2025-10-29	SELL	-245	90.180	94.420	93.996	USD -23,029	77.08 Loss of -4,145 on sale
2025-10-23	SELL	-70	89.310	89.560	89.535	USD -6,267	76.29 Loss of -927 on sale
2025-10-21	SELL	-70	87.300	87.480	87.462	USD -6,122	75.96 Loss of -805 on sale
2025-10-16	SELL	-35	87.310	92.860	92.305	USD -3,231	75.47 Loss of -589 on sale
2025-10-14	SELL	-140	85.960	86.160	86.140	USD -12,060	75.11 Loss of -1,544 on sale
2025-09-26	SELL	-70	82.700	82.950	82.925	USD -5,805	73.86 Loss of -635 on sale
2025-09-18	SELL	-70	86.000	86.070	86.063	USD -6,024	73.50 Loss of -879 on sale
2025-08-21	SELL	-140	86.530	86.970	86.926	USD -12,170	71.84 Loss of -2,111 on sale
2025-08-20	SELL	-175	86.200	86.370	86.353	USD -15,112	71.55 Loss of -2,591 on sale
2025-08-18	SELL	-105	84.920	87.240	87.008	USD -9,136	70.95 Loss of -1,686 on sale
2025-08-12	SELL	-595	81.610	81.820	81.799	USD -48,670	70.37 Loss of -6,800 on sale
2025-08-07	SELL	-420	78.200	78.250	78.245	USD -32,863	69.77 Loss of -3,560 on sale
2025-08-04	SELL	-70	78.040	78.250	78.229	USD -5,476	69.35 Loss of -621 on sale
2025-07-31	SELL	-70	74.890	77.460	77.203	USD -5,404	69.04 Loss of -572 on sale
2025-07-30	SELL	-455	77.550	78.770	78.648	USD -35,785	68.80 Loss of -4,481 on sale
2025-07-29	SELL	-245	77.380	77.870	77.821	USD -19,066	68.55 Loss of -2,270 on sale
2025-07-28	SELL	-315	70.160	70.930	70.853	USD -22,319	68.51 Loss of -739 on sale
2025-07-22	SELL	-35	68.900	69.120	69.098	USD -2,418	68.44 Loss of -23 on sale
2025-07-18	BUY	36	67.860	69.430	69.273	USD 2,494	68.50
2025-07-17	BUY	35	68.940	69.650	69.579	USD 2,435	68.48
2025-07-16	SELL	-280	69.230	69.420	69.401	USD -19,432	68.45 Loss of -265 on sale
2025-07-15	SELL	-210	68.250	70.150	69.960	USD -14,692	68.46 Loss of -315 on sale
2025-07-10	BUY	210	70.340	70.620	70.592	USD 14,824	68.39
2025-07-09	SELL	-175	68.720	69.300	69.242	USD -12,117	68.38 Loss of -152 on sale
2025-07-08	SELL	-960	67.670	68.650	68.552	USD -65,810	68.41 Loss of -141 on sale
2025-06-26	SELL	-35	70.810	71.500	71.431	USD -2,500	68.36 Loss of -107 on sale
2025-06-24	SELL	-119	69.010	69.540	69.487	USD -8,269	68.37 Loss of -133 on sale
2025-06-20	SELL	-720	68.460	69.190	69.117	USD -49,764	68.44 Loss of -485 on sale
2025-06-17	SELL	-1,500	68.810	70.890	70.682	USD -106,023	68.44 Loss of -3,362 on sale
2025-06-13	SELL	-175	67.750	68.960	68.839	USD -12,047	68.21 Loss of -110 on sale
2025-06-12	BUY	170	69.220	69.540	69.508	USD 11,816	68.08
2025-06-09	SELL	-385	69.890	69.960	69.953	USD -26,932	67.17 Loss of -1,071 on sale
2025-06-06	SELL	-105	68.770	68.980	68.959	USD -7,241	66.77 Loss of -230 on sale
2025-06-04	SELL	-665	67.420	68.450	68.347	USD -45,451	66.21 Loss of -1,421 on sale
2025-06-03	SELL	-175	67.110	70.970	70.584	USD -12,352	65.31 Loss of -923 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of INCY

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	321,923	395	451,110	71.4%
2025-09-18	244,947	1,423	469,747	52.1%
2025-09-17	277,858	779	546,953	50.8%
2025-09-16	359,781	946	576,379	62.4%
2025-09-15	347,453	4	582,228	59.7%
2025-09-12	353,040	0	631,534	55.9%
2025-09-11	448,733	3,894	739,701	60.7%
2025-09-10	490,727	248	671,932	73.0%
2025-09-09	515,395	1,822	682,791	75.5%
2025-09-08	308,184	119	479,828	64.2%
2025-09-05	256,719	2,505	512,049	50.1%
2025-09-04	422,624	1,507	834,717	50.6%
2025-09-03	381,679	7,777	624,922	61.1%
2025-09-02	547,120	15,396	816,267	67.0%
2025-08-29	148,294	262	304,427	48.7%
2025-08-28	164,008	0	347,480	47.2%
2025-08-27	248,926	453	513,401	48.5%
2025-08-26	365,130	6	709,320	51.5%
2025-08-25	478,130	1,306	642,319	74.4%
2025-08-22	344,352	2,023	596,301	57.7%
2025-08-21	198,729	4,881	335,301	59.3%
2025-08-20	351,699	3,977	555,345	63.3%
2025-08-19	343,110	3,146	574,328	59.7%
2025-08-18	366,124	4,996	653,103	56.1%
2025-08-15	480,885	8,035	625,797	76.8%
2025-08-14	593,554	36,654	806,068	73.6%
2025-08-13	845,181	98,160	1,257,503	67.2%
2025-08-12	462,896	42,208	678,689	68.2%
2025-08-11	385,211	696	595,892	64.6%
2025-08-08	248,925	738	426,187	58.4%
2025-08-07	268,864	929	420,486	63.9%
2025-08-06	554,642	891	731,484	75.8%
2025-08-05	361,687	2,092	623,879	58.0%
2025-08-04	338,005	1,464	519,150	65.1%
2025-08-01	414,814	828	572,879	72.4%
2025-07-31	570,845	6,148	777,417	73.4%
2025-07-30	471,303	14,166	881,194	53.5%
2025-07-29	966,640	10,581	1,593,701	60.7%
2025-07-28	382,236	62	625,510	61.1%
2025-07-25	216,967	49	422,990	51.3%
2025-07-24	348,276	23	528,517	65.9%
2025-07-23	297,903	583	487,297	61.1%
2025-07-22	267,987	172	446,489	60.0%
2025-07-21	223,626	380	406,729	55.0%
2025-07-18	241,218	108	471,589	51.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.